Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Chemoradiation vs Chemotherapy in Cholangiocarcinoma
NCT02773485Phase 3Unknown
- Sponsor
- Tata Memorial Hospital
- Start
- May 2015
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Tata Memorial Hospital. Primary endpoint: Overall Survival at 3 years. Status: unknown.
Beyond the preview
Go deeper on NCT02773485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02773485.